IRCCS Ospedale Policlinico San Martino
- Address
- lock Available on a paid plan
Neoplasms and Oncology Research
At IRCCS Ospedale Policlinico San Martino in Genoa, clinical trials in the Department of Internal Medicine and Medicine Specialities focus on neoplasms, with a strong emphasis on non-small cell lung cancer. This research is aimed at evaluating new treatment options and comparing their ability to improve patient outcomes in a difficult-to-treat cancer setting.
- Studies in non-small cell lung cancer
- Evaluation of new therapies versus established treatment options
- Assessment of survival and disease control in patients with advanced cancer
The trials at this site are designed to better understand how emerging cancer treatments may affect overall disease management, with attention to effectiveness in previously treated patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 25 therapeutic areas and 15 of 623 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 585 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 140 by active trials.
- 1Novartis Pharma AG12active
lock +139 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB23trials
lock +80 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in IRCCS Ospedale Policlinico San Martino
lock Showing 1 of 478 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| "APalutamide and stEReotactic body radiation therapy for low burden metastatic hormone senSItive prostate cancer, a rANdomized trial -PERSIAN". | Fondazione Radioterapia Oncologica Onlus | Phase II | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 623 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 35 | Unknown | 2015-07-16 | 2026-06-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.